What's in Hisamitsu Pharmaceutical Co., Inc.'s pipeline?

Hisamitsu Pharmaceutical Co., Inc. has 6 drugs in our index: 3 marketed, 0 filed, 1 in Phase 3, 2 in Phase 2, 0 in Phase 1.

Which companies overlap with Hisamitsu Pharmaceutical Co., Inc.'s portfolio?

Top competitors by shared drug class: , Sun Yat-sen University, Pfizer, Abbott, Amzell.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/hisamitsu-pharmaceutical-co-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Hisamitsu Pharmaceutical Co., Inc. — Portfolio Competitive Intelligence Brief

Hisamitsu Pharmaceutical Co., Inc. pipeline: 3 marketed, 0 filed, 1 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 1 Phase 3 2 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Voltaren	DICLOFENAC	marketed	Nonsteroidal Anti-inflammatory Drug	Prostaglandin G/H synthase 2	Oncology	1988-01-01
Ditropan Xl	OXYBUTYNIN	marketed	Cholinergic Muscarinic Antagonist	Muscarinic acetylcholine receptor M3	Metabolic	1975-01-01
FS-67 Patch	FS-67 Patch	marketed
HKT-500 Ketoprofen Topical Patch	HKT-500 Ketoprofen Topical Patch	phase 3	Nonsteroidal anti-inflammatory drug (NSAID)	Cyclooxygenase (COX-1 and COX-2)	Pain Management / Rheumatology

Therapeutic area mix

Metabolic · 1
Oncology · 1
Pain Management / Rheumatology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

· 2 shared drug classes
Sun Yat-sen University · 2 shared drug classes
Pfizer · 2 shared drug classes
Abbott · 1 shared drug class
Amzell · 1 shared drug class
Assaf-Harofeh Medical Center · 1 shared drug class
Amneal Pharmaceuticals, LLC · 1 shared drug class
Astellas Pharma · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Hisamitsu Pharmaceutical Co., Inc.:

Cite this brief

Drug Landscape (2026). Hisamitsu Pharmaceutical Co., Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/hisamitsu-pharmaceutical-co-inc. Accessed 2026-05-16.